BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Vivanza Biosciences Ltd Industry :  Trading
BSE Code
530057
ISIN Demat
INE984E01035
Book Value (Rs)
1.1
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
8
P/E (TTM)
14.62
EPS (TTM)
0.13
Face Value
(Rs)
1
Back
Vivanza Biosciences reports consolidated net loss of Rs 0.45 crore in the March 2026 quarter
08-May-26   Hrs IST

Net Loss of Vivanza Biosciences reported to Rs 0.45 crore in the quarter ended March 2026 as against net loss of Rs 1.00 crore during the previous quarter ended March 2025. Sales rose 1225.00% to Rs 6.36 crore in the quarter ended March 2026 as against Rs 0.48 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.39 crore in the year ended March 2026 as against net loss of Rs 0.67 crore during the previous year ended March 2025. Sales rose 1462.13% to Rs 115.91 crore in the year ended March 2026 as against Rs 7.42 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.360.48 1225 115.917.42 1462
OPM %-3.62-200.00 -0.63-4.85 -
PBDT-0.29-0.99 71 0.57-0.65 LP
PBT-0.30-0.99 70 0.54-0.67 LP
NP-0.45-1.00 55 0.39-0.67 LP

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)